Iphaneli yovavanyo ye-AMP/BAR/BZO/COC/MOP/THC
Usetyenziso olucetywayo
Inyathelo elinye i-AMP/BAR/BZO/COC/MOP/THC Test Panel yi-lateral flow chromatographic immunoassay yokubhaqa i-Amphetamine, iBarbiturates, iCocaine, iMethamphetamine, iOpiate kunye neMarijuana kumchamo womntu.
Uvavanyo | Isilinganisi | Yisuse ecaleni |
I-AMP | IAmphetamine | 1000ng/ml |
IBHA | IiBarbiturates | 300ng/ml |
BZO | Benzodiazepines | 300ng/ml |
COC | Cocaine | 300ng/ml |
I-MOP | Morphine (Opiate) | 300ng/ml |
I-THC | Intsangu | 50ng/ml |
Olu vavanyo lubonelela kuphela iziphumo zovavanyo lokuqala.Kufuneka kusetyenziswe enye indlela yeekhemikhali ezizezinye ngakumbi ukuze kufunyanwe iziphumo zohlalutyo eziqinisekisiweyo.Ichromatography yegesi/i-mass spectrometry (GC/MS) yeyona ndlela ithandwayo yokuqinisekisa.Uqwalaselo lwezonyango kunye nesigwebo sobuchule kufuneka sisetyenziswe kuso nasiphi na isiphumo sovavanyo lokusetyenziswa kakubi kweziyobisi, ngakumbi xa kusetyenziswa iziphumo zokuqala eziqinisekisayo.
Umgaqo
I-AMP/BAR/BZO/COC/MOP/THC Iphaneli yoVavanyo yenzelwe ukubona i-Amphetamine, iBarbiturates, iBenzodiazepines, iCocaine, iMorphine kunye neMarijuana ngokutolika okubonakalayo kophuhliso lombala kumgca.I-membrane yayingashukumi kunye neDrug antigens conjugates kwingingqi yovavanyo, kwaye iphedi yesampulu yayifakwe ngaphambili ngemibala echasene neziyobisi ezilwa ne-colloidal conjugates zegolide.Emva kokuba imizekelo yongeziweyo, i-conjugates yegolide ihamba ecaleni kwe-membrane chromatographically ngesenzo se-capillary kunye nee-antibodies zifika kwindawo yovavanyo.Ukuba akukho molekyuli yechiza emchameni i-antibody conjugate yegolide inokuncamathela kwiconjugate yechiza ukwenza umgca obonakalayo.Ngoko ke, ukubunjwa kwe-precipitant ebonakalayo kummandla wokuvavanya kwenzeka xa umchamo ungalunganga kwiyeza.Ukuba i-Amphetamine, i-Barbiturates, i-Cocaine, i-Methamphetamine, i-Opiate kunye ne-Marijuana zikhona emchameni, i-antigen yechiza ikhuphisana ne-conjugate yechiza elingashukumiyo kummandla wovavanyo lweendawo ezilinganiselweyo ze-antibody.Kwimeko yoxinaniso olwaneleyo lwechiza, lizalisa iindawo ezibophelelayo ze-antibody.Oku kuya kuthintela uncamathiselo lwe-antibody-colloidal gold conjugate enemibala kwindawo yokudibanisa ichiza kwindawo yovavanyo.Ngoko ke, ukungabikho kwebhanti enemibala kwindawo yokuvavanya kubonisa umphumo omuhle.Ukubonakala kwebhanti enemibala kwindawo yokulawula isebenza njengolawulo lwenkqubo.Oku kubonisa ukuba umthamo ofanelekileyo we-specimen wongeziwe kwaye i-membrane wicking yenzeke.
Amacandelo eKit
Iiphaneli zovavanyo | Iipayipi ezilahlayo | Ukupakisha Faka |
Izinto Eziyimfuneko Kodwa Ezingabonelelwanga
Isibali-xesha | Isingxobo sokuqokelelwa kwesampuli |
Ukulumkela
★ Ukusetyenziswa koxilongo lwe-in vitro kuphela.
★ Ungasebenzisi emva komhla wokuphelelwa oboniswe kwiphakheji.Musa ukulusebenzisa uvavanyo ukuba isingxobo sefoyile saso sonakalisiwe.Musa ukuphinda usebenzise iimvavanyo.
★ Le khithi iqulethe iimveliso zemvelaphi yezilwanyana.Ulwazi oluqinisekisiweyo lwemvelaphi kunye / okanye ubume bococeko lwezilwanyana aluqinisekisi ngokupheleleyo ukungabikho kwee-agent ze-pathogenic ezihambisayo.Kuyacetyiswa ke ngoko ukuba ezi mveliso ziphathwe njengenokosulela, kwaye ziphathwe ngokuqwalasela imiqathango yokhuseleko yesiqhelo (ungagilisi okanye ukusezele umoya).
• Kuphephe ukungcoliseka ngokunqamlezayo kwesampulu ngokusebenzisa isikhongozeli esitsha sokuqokelelwa kwesampulu kumzekelo ngamnye ofunyenweyo.
★ Funda inkqubo yonke ngononophelo phambi kokwenza naluphi na uvavanyo.
★ Sukutya, usele okanye utshaye kwindawo apho imizekelo neekiti ziphathwa khona.Phatha yonke imizekelo ngokungathi inee-arhente ezosulelayo.Qwalasela izilumkiso ezimiselweyo malunga nobungozi be-microbiological kuyo yonke inkqubo kwaye ulandele iinkqubo ezisemgangathweni zokulahla ngokufanelekileyo iisampulu.Nxiba iimpahla ezikhuselayo ezifana needyasi zaselabhoratri, iiglavu ezilahlwayo kunye nokhuseleko lwamehlo xa imizekelo ivavanywa.
★ Ukufuma kunye nobushushu bunokuchaphazela kakubi iziphumo.
★ Izinto zokuvavanya ezisetyenzisiweyo kufuneka zilahlwe ngokuhambelana nemimiselo yendawo, urhulumente kunye / okanye i-federal.
Ukugcinwa kunye nokuzinza
✽ Ikhithi kufuneka igcinwe kwi-2-30°C de kube ngumhla wokuphelelwa kwexesha uprintwe kwisingxobo esivaliweyo.
✽ Uvavanyo maluhlale kwisingxobo esitywiniweyo de lusetyenziswe.
✽ Musa ukuba ngumkhenkce.
✽ Kufuneka kuthatyathwe inkathalo ukukhusela amalungu ale khithi ekosulelweni.Musa ukusebenzisa ukuba kukho ubungqina bokungcoliseka kwe-microbial okanye imvula.Ungcoliseko lwebhayoloji lwezixhobo zokukhupha, izikhongozeli okanye iirejenti kunokukhokelela kwiziphumo ezingezizo.
Ukuqokelelwa komfanekiso kunye noGcino
✔ Iphaneli yoVavanyo ye-AMP/BAR/BZO/COC/MOP/THC yenzelwe kuphela ukusetyenziswa nemizekelo yomchamo womntu.
✔ Umchamo oqokelelweyo kufuneka ufakwe kwizikhongozeli ezicacileyo nezomileyo.Qinisekisa ukuba umyinge owaneleyo womfanekiso uqokelelwe ukuvumela ukuntywiliselwa kwindawo yokudipha yomcu.
✔ Yenza uvavanyo ngoko nangoko emva kokuqokelelwa komfanekiso.Musa ukushiya imizekelo kwiqondo lobushushu begumbi ixesha elide.Imizekelo ingagcinwa kwi-2-8 ° C ukuya kwiiyure ezingama-48.Ukugcina ixesha elide, imizekelo kufuneka igcinwe ngaphantsi kwe-20°C.
✔ Zisa iisampulu kwiqondo lobushushu legumbi ngaphambi kovavanyo.Iisampulu ezikhenkcezisiweyo kufuneka zinyibilike ngokupheleleyo kwaye zixutywe kakuhle phambi kovavanyo.Kuphephe ukukhenkceza okuphindaphindiweyo kunye nokunyibilika kwemizekelo.
✔ Pakisha imizekelo ngokuhambelana nemigaqo esebenzayo yokuthutha i-etiological agents, xa kufuneka zithunyelwe.
Inkqubo
Zisa iimvavanyo, imizekelo, kunye/okanye nolawulo kwiqondo lobushushu legumbi (15-30°C) phambi kokusetyenziswa.
1.Susa indawo yolawulo kwisingxobo sayo esitywiniweyo kwaye uyisebenzise ngokukhawuleza.Ukufumana iziphumo ezingcono, uvavanyo kufuneka lwenziwe kwiyure enye.
2. Qokelela umchamo kwikomityi yomchamo, faka ipaneli yokuvavanya kumchamo kwaye uqinisekise ukuba umchamo awudluli umgca omkhulu.
3.Isiphumo kufuneka sifundwe ngemizuzu emi-5.Musa ukutolika umphumo emva kwemizuzu engama-20.
Izilumkiso zokuSebenzisa
IZIPHUMO EZINYO: ![]()
| * Ibhendi enemibala ibonakala kwingingqi yebhanti yolawulo (C) kwaye enye ibhendi enemibala ibonakala kwindawo ye-T band. |
IZIPHUMO EZINGAMBI: ![]()
| Ibhendi enye enemibala ibonakala kwingingqi yebhanti yolawulo (C).Akukho bhendi ivela kummandla webhendi yovavanyo (T). |
IZIPHUMO EZINGAVUMI: ![]()
| Ibhendi yolawulo ayibonakali.Iziphumo zalo naluphi na uvavanyo olungakhange luvelise ibhendi yolawulo ngexesha lokufunda elichaziweyo mazichithwe.Nceda ujonge inkqubo kwaye uphinde ngovavanyo olutsha.Ukuba ingxaki iyaqhubeka, yeka ukusebenzisa ikhithi ngoko nangoko kwaye uqhagamshelane nomsasazi wakho wendawo. |
Phawula
1. Ubunzulu bombala kwingingqi yovavanyo (T) bunokwahluka ngokuxhomekeka kugxininiso lwezinto ezijoliswe kuzo ezikhoyo kumzekelo.Ngoko ke, nawuphi na umthunzi wombala kummandla wovavanyo kufuneka uthathwe njengento embi.Ngaphandle koko, inqanaba logxininiso alinakumiselwa ngolu vavanyo lomgangatho.
2.I-specimen enganelanga umthamo, inkqubo yokusebenza engachanekanga, okanye ukwenza iimvavanyo eziphelelwe lixesha zizona zizathu ezinokwenzeka zokungaphumeleli kwebhendi yolawulo.
Ulawulo lwemeko
★ Ulawulo lwenkqubo lwangaphakathi lubandakanyiwe kuvavanyo.Ibhendi enemibala ebonakala kummandla wolawulo (C) ithathwa njengolawulo olulungileyo lwangaphakathi.Iqinisekisa umthamo owaneleyo wesampuli kunye nobuchule benkqubo obuchanekileyo.
★ Ulawulo lwangaphandle alubonelelwanga nale khithi.Kucetyiswa ukuba ulawulo oluqinisekileyo nolungalunganga luvavanywe njengenkqubo efanelekileyo yaselabhoratri ukuqinisekisa inkqubo yovavanyo kunye nokuqinisekisa ukusebenza kakuhle kovavanyo.
Imida yoVavanyo
1.I-AMP/BAR/BZO/COC/MOP/THC Test Panel is for professional in vitro diagnostic use, kwaye kufuneka isetyenziselwe ukufunyaniswa komgangatho we-morphine kunye nezinye i-opiates kuphela.
2.I-AMP/BAR/BZO/COC/MOP/THC Test Panel ibonelela kuphela ngobuninzi, isiphumo sokuqala sokuhlalutya.Indlela yesibini yohlalutyo kufuneka isetyenziswe ukufumana umphumo oqinisekisiweyo.Ichromatography yegesi/i-mass spectrophotometry (GC/MS) yeyona ndlela ithandwayo yokuqinisekisa.
3.Nceda uthathe okucacileyo kunye ne-cross reactivity kwi-akhawunti yokuvavanya
4.Isiphumo esihle kunye naluphi na uvavanyo lubonisa ubukho beziyobisi / i-metabolite kuphela, kwaye ayibonisi okanye ilinganise ukuxiliswa.
5.Isiphumo esibi sinokungabonisi umchamo ongenaziyobisi.Iziphumo ezibi zinokufumaneka xa ichiza likhona kodwa lingaphantsi kwenqanaba lokunqunyulwa kovavanyo.
6.Kunokwenzeka ukuba iimpazamo zobugcisa okanye zenkqubo kunye nezinye izinto kunye nezinto ezingadweliswanga zingaphazamisa uvavanyo kwaye zibangele iziphumo zobuxoki.
7.Uvavanyo lwenzelwe ukusetyenziswa nomchamo womntu kuphela.Ngenxa yokungabikho kwee-ion kunye nezinye izinto kumanzi acocekileyo ukusetyenziswa okanye amanzi asulungekileyo kuvavanyo kunokukhokelela kwiziphumo ezibubuxoki okanye ezingasebenziyo.
I-8.Ukutya kunye neti equkethe iimveliso zepoppy (imvelaphi ye-opiates) inokuvelisa isiphumo esihle.
9.Uvavanyo alwehluli phakathi kweziyobisi zokuxhatshazwa kunye namayeza athile.
Iimpawu zokuSebenza
Uvakalelo lohlalutyo
Ichibi lomchamo elingenazo iziyobisi lixutywe ngamachiza kwezi zigxininiso zilandelayo: +/- 25%, +/- 50% kunye nokunqunyulwa.Idatha ishwankathelwa ngezantsi:
Ipesenti yokusikwa | n | I-AMP | IBHA | BZO | |||
- | + | - | + | - | + | ||
0 | 30 | 30 | 0 | 30 | 0 | 30 | 0 |
-50% | 30 | 30 | 0 | 30 | 0 | 30 | 0 |
-25% | 30 | 23 | 7 | 28 | 2 | 30 | 0 |
Yisuse ecaleni | 30 | 9 | 21 | 4 | 26 | 3 | 27 |
+ 25% | 30 | 1 | 29 | 0 | 30 | 0 | 30 |
+50% | 30 | 0 | 30 | 0 | 30 | 0 | 30 |
Ipesenti yokusikwa | n | COC | I-MOP | I-THC | |||
- | + | - | + | - | + | ||
0 | 30 | 30 | 0 | 30 | 0 | 30 | 0 |
-50% | 30 | 30 | 0 | 30 | 0 | 30 | 0 |
-25% | 30 | 30 | 0 | 27 | 3 | 30 | 0 |
Yisuse ecaleni | 30 | 4 | 26 | 5 | 25 | 7 | 23 |
+ 25% | 30 | 0 | 30 | 0 | 30 | 0 | 30 |
+50% | 30 | 0 | 30 | 0 | 30 | 0 | 30 |
UkuCacisa okuHlalutyayo
Le theyibhile ilandelayo idwelisa iikhompawundi ezifunyaniswe ngokuqinisekileyo kumchamo yi-AMP One Step Amphetamine Test Strip (Urine) ngemizuzu emi-5.
Compound eNxulumeneyo | Ugxininiso (ng/mL) |
I-AMP | |
D-Amphetamine | 1,000 |
D,L-Amphetamine sulfate | 3,000 |
L-Amphetamine | 50,000 |
(±) 3,4-MethylenedioxyAmphetamine | 2,000 |
Phentermine | 3,000 |
IBHA | |
Secobarbital | 300 |
Amobarbital | 300 |
Alphenol | 150 |
Aprobarbital | 200 |
I-Butalbital | 2,500 |
I-Buthal | I-100 |
Cyclopentobarbital | 600 |
Ipentobarbital | 300 |
I-Butabarbital | 75 |
Phenobarbital | I-100 |
BZO | |
Alprazolam | 125 |
Bromazepam | 625 |
I-Chlordiazepoxide | 2,500 |
Clobazam | 63 |
I-Clonazepam | 2,500 |
Clorazepate dipotassium | 3,330 |
Delorazepam | 2,500 |
Desalkylflurazepam | 250 |
Diazepam | 250 |
Estazolam | 5,000 |
I-Flunitrazepam | 375 |
(±) ILorazepam | 1,250 |
RS-Lorazepam glucuronide | 1,250 |
Midazolam | 100,000 |
Nitrazepam | 25,000 |
Norchlordiazepoxide | 250 |
Nordiazepam | 500 |
Oxazepam | 300 |
Sulindac | 100,000 |
Temazepam | 63 |
I-Triazolam | 5,000 |
COC | |
Ibenzoylecgonine | 300 |
I-Cocaine HCl | 780 |
Cocaethylene | 12,500 |
I-MOP | |
Codeine | 300 |
Ethylmorphine | 6,250 |
IHydrocodone | 50,000 |
I-Hydromorphone | 3,125 |
Levophanol | 1,500 |
6-Monoacethylmorphine | 400 |
Morphine | 300 |
I-Morphine 3-bD-glucuronide | 1,000 |
Norcodeine | 6,250 |
Normorphone | 100,000 |
I-Oxycodone | 30,000 |
I-oxymorphone | 100,000 |
Iprocaine | 15,000 |
Thebaine | 6,250 |
I-THC | |
I-11-nor-Δ9-THC-9-COOH | 50 |
I-11-nor-Δ8-THC-9-COOH | 50 |
I-11-hydroxy-Δ9-Tetrahydrocannabinol | 20000 |
Δ8-Tetrahydrocannabinol | 15000 |
Δ9-Tetrahydrocannabinol | 20000 |
I-Cannabinol | 20000 |
I-Cannabidiol | 100000 |
Ezi khompawundi zilandelayo zivelise iziphumo ezingalunganga ukuya kuxinzelelo lwe-100 µg/mL:
I-4-Acetamidophenol | Estrone-3-sulfate | Oxolinic acid |
Acetophenetidin | Ethyl-p-aminobenzoate | I-Oxycodone |
N-Acetylprocainamide | I-Fenfluramine | Oxymetazoline |
Acetylsalicylic acid | I-Fenoprofen | Papaverine |
Aminopyrine | Furosemide | I-Penicillin-G |
Amitryptyline | Iasidi yeGentic | I-Pentazocine |
Amobarbital | IHemoglobin | Ipentobarbital |
Amoxicillin | Hydralazine | Perphenazine |
Ampicillin | IHydrochlorothiazide | Phencyclidine |
L-Ascorbic acid | IHydrocodone | Phenelzine |
I-Apomorphine | IHydrocortisone | Phenobarbital |
Aspartame | p-HydroxyAmphetamine | L-Phenylephrine |
Atropine | O-Hydroxyhippuric acid | I-Brompheniramine |
Benzilic acid | 3-Acetate | Phenylpropanolamine |
Benzoic acid | I-acetaminophen | I-Prednisolone |
Ibenzoylecgonine | 3-Hydroxytyramine | I-Prednisone |
Ibenzphetamine | Ibuprofen | Iprocaine |
Bilirubin | Imipramine | Promazine |
(±) - iBrompheniramine | (±) - Isoproterenol | Promethazine |
Icaffeine | Isoxsuprine | D,L-Propanolol |
I-Cannabidiol | Ketamine | I-D-Propoxyphene |
I-Cannabinol | Ketoprofen | D-Pseudoephedrine |
I-Chloralhydrate | Labetalol | I-Quinidine |
Chloramphenicol | Levorphanol | I-quinine |
I-Chlordiazepoxide | Loperamide | I-Ranitidine |
I-Chlorothiazide | Maprotiline | Salicylic acid |
(±) I-Chlorpheniramine | Meperidine | Secobarbital |
I-Chlorpromazine | Meprobamate | Nalorphine |
I-Chlorquine | IMethadone | Iproniazid |
ICholesterol | I-D-methAmphetamine | Sulfamethazine |
I-Clomipramine | (L)-methAmphetamine | Sulindac |
I-Clonidine | Methoxyphenamine | Temazepam |
ICocaine hydrochloride | iTetrahydrocortisone, | Tetracycline |
Codeine | Phentermine | I-acetone |
Cortisone | L-Epinephrine | (-)-ψ-Ephedrine |
(-) I-Cotinine | b-Phenylethylamine | (-) Y Ephedrine |
I-Creatinine | Methylphenidate | I-Chlorpheniramin |
Deoxycorticosterone | (1R,2S)-(-)-Ephedrine | Tetrahydrozoline |
Dextromethorphan | D,L-Amphetamine sulfate | Thebaine |
Diazepam | Nalidixic acid | Thiamine |
I-Diclofenac | Naloxone | I-Thioridazine |
I-Diflunisal | Naltrexone | Tolbutamine |
Digoxin | Naproxen | I-Triamterene |
Idiphenhydramine | Niacinamide | I-Trifluoperazine |
Doxylamine | Nifedipine | I-Trimethoprim |
Ecgonine hydrochloride | Norcodein | D,L-Propranolol |
Ecgonine methylester | Norethindrone | D, L-Tryptophan |
(IR,2S)-(-)-Ephedrine | D-Norpropoxyphene | Tyramine |
L-Ephedrine | Noscapine | D, L-Tyrosine |
(-)-ψ- Ephedrine | D, L-Octopamine | Uric acid |
Erythromycin | Oxalic acid | Verapamil |
b-Estradiol | Oxazepam | Zomepirac |
Cocaethylene | (±) - 3,4-Methylenedioxy- | (±)-Brompheniramine |
(±) Isoproterenol | iamphetamine | 3-Acetate |
I-Morphine Sulfate | (±) - 3,4-Methylenedioxy | D,L-Tyrosine |
Tolbutamide | imethmphetamine | 3-(bD-glucuronide) |
(±) - I-Chlorpheniramine | I-Quinacrine | MDE |
(-) -ψ-Ephedrine | Dicyclomine | I-Tryptamine |
[1R,2S] (-) Ephedrine | Mehentermine | D,L-Tryptophan |
L - Epinephrine | D/L-Propranolol | L-Ψ-Ephedrine |
Quindine | Buspirone | I-Aspirin |
I-Chloroquine | D-Amphetamine | L-Amphetamine |
Phenolbarbital | D,L-Amphetamine | Pheniramine |
I-Nimesulide | Creatin | Phenothiazine |
b-Hydroxynorephedrtne | Dexbrompheniramine | Phenylethylamine |
D/L-Tryptophan | D / L-Octopamine | UQuinjdin |
Tetrahydrocortisone | IDopamine | I-Ranitidin |
propylamine | I-Ethanol | Riboflavine |
(±) -Brompheniramine | 3-(bD glucuronide) | IGlucose |
I-Chloroquin | (+/-)-Isoproterenol | I-Sodium chloride |
L-Epinephrine | Albumin | Thioridazin |
Theophylline | Lidocaine | I-Trifluoperazin |
D/L-Chloropheniramine | Amitriptylin | I-Trimethobenzamid |
Imipramin | I-3-acetate | Ivithamin C |
(-)Isoproterenol | D/L-Tyrosine | Benzocaine |
(±) -Isoproterenol | Trazodone | ikofu |
Trans-2-phenylcyclopropylamine | p-Hydroxy-methAmphetamine | IGuiacol Glyceryl Ether |
I-Tetrahydrocortisone 3 (bD glucuronide) | I-4-Dimethylaminoantipyrine | (+/-)-Chlorpheniramin |
(+)3,4-Methylenedioxy-amphetamine | I-Morphine-3-bD glucuronide | I-Morphine-3-bD-glucuronide |
Trans-2-phenylcyclo-propylamine hydrochloride | 3,4-Methylenedioxyethyl-Amphetamine | (+) 3,4-Methylenedioxy-methAmphetamine |
I-Tetrahydrocortisone 3 (bD glucuronide) | Pentazocine hydrochloride | Tetrahydrocortisone, 3 Acetate |
ISerotonin (5-Hydroxytyramine) | (+) 3,4-Methylenedioxy-amphetamine |
Iimbekiselo zoncwadi
I-1.Baselt, i-RC Disposition ye-Toxic Drugs kunye neeKhemikhali kuMntu, i-Biomedical Publications, i-1982.
2.UVavanyo loMchamo kwiZiyobisi zokuSebenzisa kakubi.Iziko leSizwe lokusetyenziswa kakubi kweziyobisi (NIDA), iMonograph yoPhando 73, 1986.
3.Thomas L. eds., Labor and Diagnose, 6. ed., TH-Books Verlags gesellschaft, Frankfurt, 2005
4.Fed.Bhalisa, iSebe lezeMpilo kunye neeNkonzo zoLuntu, iziKhokelo eziMandatory for Federal Workplace Drug Testing Programs, 53, 69, 11970, 1988.
5.McBay, AJ Clin.Ikhem.33, 33B-40B, 1987.